COVID-19 Vaccines and Herd Immunity

COVID-19 Vaccines and Herd Immunity

With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.

Related Article:

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

Avsnitt(227)

The Winter COVID-19 Surge in New York and Los Angeles

The Winter COVID-19 Surge in New York and Los Angeles

Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses causes, similarities, and differences betw...

15 Jan 202110min

Coronavirus Vaccine Update With Arnold S. Monto, MD

Coronavirus Vaccine Update With Arnold S. Monto, MD

Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EU...

13 Jan 202130min

An Opportune Time to Update Medical Licensing

An Opportune Time to Update Medical Licensing

Interview with Samyukta Mullangi, MD, MBA, author of The COVID-19 Pandemic—An Opportune Time to Update Medical Licensing; also with Mitchell H. Katz, MD, chief executive officer of New York City Heal...

13 Jan 202123min

Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing

Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing

Aaloke Mody, MD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study that uses Lorenz curves as a metric for quantifying racial inequities in corona...

12 Jan 202112min

Understanding the New SARS-CoV-2 Mutation Found in England

Understanding the New SARS-CoV-2 Mutation Found in England

Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2. Related Article(s): Genetic Variants o...

8 Jan 202113min

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23,...

6 Jan 202116min

Understanding SARS-CoV-2 Genetic Variants

Understanding SARS-CoV-2 Genetic Variants

Adam Lauring, MD, PhD, from the University of Michigan Division of Infectious Diseases, an expert on the evolutionary biology of RNA viruses, explains the new genetic variants recently found in SARS-C...

6 Jan 202140min

Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California

Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California

Nicole Kravitz-Wirtz, PhD, MPH, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study describing individuals' concerns regarding violence in the context of the...

5 Jan 202112min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
svd-nyhetsartiklar
det-morka-psyket
kapitalet-en-podd-om-ekonomi
doden-hjarnan-kemisten
sexet
rss-ufo-bortom-rimligt-tvivel-2
rss-vetenskapsradion-2
paranormalt-med-caroline-giertz
rss-vetenskapsradion
medicinvetarna
bildningspodden
har-vi-akt-till-mars-an
dumforklarat
rss-spraket
hacka-livet
vetenskapsradion
4health-med-anna-sparre